PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
BBP vs. BBC
Performance
Return for Risk
Drawdowns
Volatility
Dividends

BBP vs. BBC

Last updated Aug 2, 2026
Documentation

BBP (Virtus LifeSci Biotech Products ETF) and BBC (Virtus LifeSci Biotech Clinical Trials ETF) are both Health & Biotech Equities funds from Virtus - BBP tracks the LifeSci Biotechnology Products Index while BBC tracks the LifeSci Biotechnology Clinical Trials Index. Both are passively managed. Over the past 10 years, BBP returned 11.65%/yr vs 9.79%/yr for BBC. Their correlation of 0.86 means they have usually moved in the same direction. Both charge a 0.79% expense ratio.

Performance

BBP vs. BBC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Virtus LifeSci Biotech Products ETF (BBP) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BBP achieves a 17.46% return, which is significantly lower than BBC's 26.39% return. Over the past 10 years, BBP has outperformed BBC with an annualized return of 11.65%, while BBC has yielded a comparatively lower 9.79% annualized return.

BBP

1D
-2.71%
1M
-5.26%
6M
15.00%
YTD
17.46%
1Y
51.33%
3Y*
19.80%
5Y*
13.17%
10Y*
11.65%
ALL TIME*
12.15%

BBC

1D
-3.05%
1M
-7.68%
6M
19.33%
YTD
26.39%
1Y
131.04%
3Y*
28.17%
5Y*
2.62%
10Y*
9.79%
ALL TIME*
6.26%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)

BBC

Virtus LifeSci Biotech Clinical Trials ETF
$567.19K$1.45M$1.29M

BBP

Virtus LifeSci Biotech Products ETF
$1.01M$1.06M$1.01M

BBP vs. BBC - Yearly Performance Comparison

2026 (YTD)202520242023202220212020201920182017
BBP
Virtus LifeSci Biotech Products ETF		17.46%33.15%3.32%17.88%0.85%-8.17%22.24%24.73%-13.95%24.07%
BBC
Virtus LifeSci Biotech Clinical Trials ETF		26.39%63.77%-1.11%-1.80%-35.13%-22.31%30.32%63.81%-18.29%57.85%

Correlation

The correlation between BBP and BBC is 0.81, meaning they have usually moved in the same direction, including during past declines.

Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.81

Correlation (3Y)
Balances recent behavior with more history.

0.84

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.86

Correlation (10Y)
Provides a long-term view across more market conditions.

0.85

Correlation (All Time)
Calculated using the full available price history since Dec 17, 2014

0.86

The correlation between BBP and BBC has been stable across timeframes, ranging from 0.81 to 0.86 - a consistent structural relationship.

BBP vs. BBC - Sectors Allocation Comparison

Sectors
BBP
BBC

Healthcare

100.0%
100.0%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

0.8%

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

BBP
100.0%
BBC
100.0%

Basic Materials

BBP

-

BBC

-

Communication Services

BBP

-

BBC

-

Consumer Cyclical

BBP

-

BBC

-

Consumer Defensive

BBP

-

BBC

-

Energy

BBP

-

BBC

-

Financial Services

BBP

-

BBC
0.8%

Industrials

BBP

-

BBC

-

Real Estate

BBP

-

BBC

-

Technology

BBP

-

BBC

-

Utilities

BBP

-

BBC

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Virtus LifeSci Biotech Products ETF

Virtus LifeSci Biotech Clinical Trials ETF

Often compared with BBP:
BBP vs. SBIOBBP vs. FBTBBP vs. IBBQBBP vs. IHEBBP vs. WDNABBP vs. FTXHBBP vs. TXG
Often compared with BBC:
BBC vs. XBIBBC vs. BBHBBC vs. IBBQBBC vs. SBIOBBC vs. QQQBBC vs. ARKGBBC vs. LLY

Return for Risk

BBP vs. BBC — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.
BBP
BBP Risk / Return Rank: 9090
Overall Rank
BBP Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
BBP Sortino Ratio Rank: 8888
Sortino Ratio Rank
BBP Omega Ratio Rank: 8383
Omega Ratio Rank
BBP Calmar Ratio Rank: 9595
Calmar Ratio Rank
BBP Martin Ratio Rank: 9292
Martin Ratio Rank
BBC
BBC Risk / Return Rank: 9696
Overall Rank
BBC Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
BBC Sortino Ratio Rank: 9595
Sortino Ratio Rank
BBC Omega Ratio Rank: 9393
Omega Ratio Rank
BBC Calmar Ratio Rank: 9797
Calmar Ratio Rank
BBC Martin Ratio Rank: 9696
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

BBP vs. BBC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Products ETF (BBP) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

BBPBBCDifference
Sharpe ratioReturn per unit of total volatility
2.20
3.55

-1.36

Sortino ratioReturn per unit of downside risk
3.02
4.01

-0.99

Omega ratioGain probability vs. loss probability

1.36

1.47

-0.12

Calmar ratioReturn relative to maximum drawdown

5.61

8.58

-2.97

Martin ratioReturn relative to average drawdown

15.91

23.49

-7.58

BBP vs. BBC - Sharpe Ratio Comparison

The current BBP Sharpe Ratio is 2.20, which is lower than the BBC Sharpe Ratio of 3.55. The chart below compares the historical Sharpe Ratios of BBP and BBC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Drawdowns

BBP vs. BBC - Drawdown Comparison

The maximum BBP drawdown since its inception was -44.32%, smaller than the maximum BBC drawdown of -76.85%. Use the drawdown chart below to compare losses from any high point for BBP and BBC.

Loading charts...

Drawdown Indicators

BBPBBCDifference

Max Drawdown

Largest peak-to-trough decline

-44.32%

-76.85%

+32.53%

Max Drawdown (1Y)

Largest decline over 1 year

-9.41%

-15.10%

+5.69%

Max Drawdown (3Y)

Largest decline over 3 years

-26.09%

-54.45%

+28.36%

Max Drawdown (5Y)

Largest decline over 5 years

-37.77%

-70.92%

+33.15%

Max Drawdown (10Y)

Largest decline over 10 years

-44.32%

-76.85%

+32.53%

Current Drawdown

Current decline from peak

-9.41%

-18.87%

+9.46%

Average Drawdown

Average peak-to-trough decline

-11.90%

-36.88%

+24.98%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.31%

5.51%

-2.20%

Volatility

BBP vs. BBC - Volatility Comparison

The current volatility for Virtus LifeSci Biotech Products ETF (BBP) is 8.02%, while Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a volatility of 10.52%. This indicates that BBP experiences smaller price fluctuations and is considered to be less risky than BBC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

BBPBBCDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.02%

10.52%

-2.50%

Volatility (6M)

Calculated over the trailing 6-month period

19.16%

26.31%

-7.15%

Volatility (1Y)

Calculated over the trailing 1-year period

24.07%

36.55%

-12.48%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

26.42%

39.60%

-13.18%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

27.34%

37.72%

-10.38%

BBP vs. BBC - Expense Ratio Comparison

Both BBP and BBC have an expense ratio of 0.79%.

Dividends

BBP vs. BBC - Dividend Comparison

BBP has not paid dividends to shareholders, while BBC's dividend yield for the trailing twelve months is around 1.34%.

PositionTTM20252024202320222021202020192018201720162015
BBC
Virtus LifeSci Biotech Clinical Trials ETF		1.34%1.70%1.00%0.34%0.00%0.00%0.00%0.00%0.00%2.09%0.00%0.51%
BBP
Virtus LifeSci Biotech Products ETF		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.18%0.00%1.29%

Frequently Asked Questions

BBP and BBC have a correlation of 0.81, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BBC has higher volatility (10.52%) compared to BBP (8.02%). In terms of maximum drawdown, BBP dropped -44.32% vs BBC's -76.85%.

On 10-year performance, BBP leads with 11.65% vs 9.79% for BBC. Both ETFs have the same 0.79% expense ratio. On volatility, BBP has been the lower-risk option at 8.02%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, BBP has performed better with a 11.65% return vs 9.79%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

BBP and BBC have the same expense ratio: 0.79% per year.

BBC has the higher dividend yield at 1.34%, compared with 0.00% for BBP.

BBP tracks LifeSci Biotechnology Products Index, while BBC tracks LifeSci Biotechnology Clinical Trials Index.

BBC currently has the higher Sharpe Ratio (3.55 vs 2.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BBP and BBC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer